Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperphosphatemia and parathyroid hyperplasia].

K Sato1

  • 1Institute of Clinical Endocrinology, Tokyo Women's Medical University.

Clinical Calcium
|March 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-activity relationships of mu-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations.

Biochemistry·1992
Same author

Hydroxyl radical production by H2O2 plus Cu,Zn-superoxide dismutase reflects the activity of free copper released from the oxidatively damaged enzyme.

The Journal of biological chemistry·1992
Same author

Depression of catalase gene expression in the liver of tumor bearing nude mice.

Biochemical and biophysical research communications·1992
Same author

Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments.

Neuroscience letters·1992
Same author

The binding of adenine nucleotides to apo-electron-transferring flavoprotein.

Journal of biochemistry·1992
Same author

[A 13-week subacute oral toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl) amino] benzoate dimethanesulfonate (FUT-187) in dogs.

The Journal of toxicological sciences·1992

Long-term oral phosphate treatment in a hypophosphatemic patient led to tertiary hyperparathyroidism. Genetic analysis suggested hyperphosphatemia, not kidney issues, may drive parathyroid gland growth.

Area of Science:

  • Endocrinology
  • Genetics
  • Nephrology

Context:

  • A patient with adult-onset osteomalacia due to hypophosphatemia underwent prolonged oral phosphate therapy.
  • Tertiary hyperparathyroidism developed after over a decade of treatment.

Purpose:

  • To investigate the genetic basis and potential causes of parathyroid gland hyperplasia in a patient with long-term phosphate therapy.

Summary:

  • Gene analysis of enlarged parathyroid glands revealed MEM1 gene abnormalities and microsatellite instability.
  • These findings suggest hyperphosphatemia itself, independent of renal function, may contribute to parathyroid nodular hyperplasia or adenoma development.

Impact:

  • This study highlights a potential mechanism linking chronic hyperphosphatemia to parathyroid disease.

Related Experiment Videos

  • It suggests that hyperphosphatemia, irrespective of renal status, could be a factor in parathyroid adenoma formation.